Results for tag: "Radiation Injury Drug"

Radiation Injury Drug market is a subset of the Liver and Kidney Disorders Drugs market. It is composed of drugs used to treat radiation-induced damage to the liver and kidneys. These drugs are used to reduce inflammation, prevent cell death, and promote tissue regeneration. They are also used to reduce the risk of long-term complications from radiation exposure. Commonly used drugs include corticosteroids, anti-inflammatory agents, and antioxidants. The Radiation Injury Drug market is a rapidly growing sector of the Liver and Kidney Disorders Drugs market. It is driven by the increasing prevalence of radiation-induced damage to the liver and kidneys, as well as the need for more effective treatments. Some companies in the Radiation Injury Drug market include AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more